Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Puerarin 6’’-O-xyloside is a flavonoid glycoside that has been found in P. lobata and has diverse biological activities.1,2,3 It induces apoptosis in A549 lung cancer cells and reduces tumor volume in an A549 mouse xenograft model when administered at a dose of 40 mg/kg.1 Puerarin 6’’-O-xyloside decreases PPARα and carnitine palmitoyltransferase 1A (CPT1A) levels in HepG2 cells stimulated by oleic acid (Item Nos. 90260 | 24659) and palmitic acid (Item Nos. 10006627 | 43561).2 It reduces serum triglyceride, total cholesterol, and LDL-C levels, fasting blood glucose levels, lipid droplet accumulation, and body weight in a model of menopause using ovariectomized mice fed a high-fat diet (HFD). Puerarin 6’’-O-xyloside induces proliferation of isolated rat osteocytes, increases serum calcium, phosphorus, alkaline phosphatase (ALP), and osteoprotegerin levels, and increases thickening of the trabecular bone in a model of osteoporosis using ovariectomized mice.3
WARNING This product is not for human or veterinary use.
1. In vitro and in vivo antitumour activities of puerarin 6″-
2. Puerarin 6″-
3. Anti-